Factors that could cause actual results to differ materially from those implied by these forward-looking statements include, but are not limited to: disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future; the effect on foreign operations of currency fluctuations, tariffs and other political, economic and regulatory risks, including recessionary conditions; the current and potential future impact of the COVID-19 pandemic on our business, results of operations, financial position or cash flows, including without limitation, any supply chain and logistics issues; changes in polymer consumption growth rates and laws and regulations regarding plastics in jurisdictions where we conduct business; fluctuations in raw material prices, quality and supply, and in energy prices and supply; production outages or material costs associated with scheduled or unscheduled maintenance programs; unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters; our ability to pay regular quarterly cash dividends and the amounts and timing of any future dividends; information systems failures and cyberattacks; amounts for cash and non-cash charges related to restructuring plans that may differ from original estimates, including because of timing changes associated with the underlying actions; any material adverse changes in the acquired DPM protective materials business; our ability to achieve the strategic and other objectives relating to the Acquisition and the possible sale of the Distribution business segment; and other factors described in our Annual Report on Form 10-K for the year ended

Factors that could cause actual results to differ materially from those implied by these forward-looking statements include, but are not limited to: disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future; the effect on foreign operations of currency fluctuations, tariffs and other political, economic and regulatory risks, including recessionary conditions; the current and potential future impact of the COVID-19 pandemic on our business, results of operations, financial position or cash flows, including without limitation, any supply chain and logistics issues; changes in polymer consumption growth rates and laws and regulations regarding plastics in jurisdictions where we conduct business; fluctuations in raw material prices, quality and supply, and in energy prices and supply; production outages or material costs associated with scheduled or unscheduled maintenance programs; unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters; our ability to pay regular quarterly cash dividends and the amounts and timing of any future dividends; information systems failures and cyberattacks; amounts for cash and non-cash charges related to restructuring plans that may differ from original estimates, including because of timing changes associated with the underlying actions; any material adverse changes in the business supporting the Distribution assets being sold; the ability to obtain required regulatory or other third-party approvals and consents and otherwise consummate the proposed sale of the Distribution business; any material adverse changes in the Protective Materials Business proposed to be acquired from Royal DSM ("DSM"); our ability to achieve the strategic and other objectives relating to the proposed acquisition of the

Factors that could cause actual results to differ materially from those implied by these forward-looking statements include, but are not limited to: disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future; the effect on foreign operations of currency fluctuations, tariffs and other political, economic and regulatory risks, including recessionary conditions; the current and potential future impact of the COVID-19 pandemic on our business, results of operations, financial position or cash flows, including without limitation, any supply chain and logistics issues; changes in polymer consumption growth rates and laws and regulations regarding plastics in jurisdictions where we conduct business; fluctuations in raw material prices, quality and supply, and in energy prices and supply; production outages or material costs associated with scheduled or unscheduled maintenance programs; unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters; our ability to pay regular quarterly cash dividends and the amounts and timing of any future dividends; information systems failures and cyberattacks; amounts for cash and non-cash charges related to restructuring plans that may differ from original estimates, including because of timing changes associated with the underlying actions; our ability to successfully integrate the Avient Protective Materials business and achieve the expected results of the business, including without limitation, the acquisition being accretive; any material adverse changes in the business supporting the Distribution assets being sold; the ability to obtain required regulatory approvals and otherwise consummate the proposed sale of the Distribution business; our ability to achieve the strategic and other objectives relating to the Avient Protective Materials business and the proposed sale of the Distribution business; and other factors described in our Annual Report on Form 10-K for the year ended

Factors that could cause actual results to differ materially from those implied by these forward-looking statements include disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future; the effect on foreign operations of currency fluctuations, tariffs and other political, economic and regulatory risks; the current and potential future impact of the COVID-19 pandemic on our business, results of operations, financial position or cash flows including without any limitation, any supply chain and logistics issues; our ability to achieve the strategic and other objectives relating to the acquisition of Clariant's Color business, including any expected synergies; changes in polymer consumption growth rates and laws and regulations regarding plastics in jurisdictions where we conduct business; fluctuations in raw material prices, quality and supply, and in energy prices and supply; production outages or material costs associated with scheduled or unscheduled maintenance programs; unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters; an inability to achieve the anticipated financial benefit from initiatives related to acquisition and integration working capital reductions, cost reductions and employee productivity goals; our ability to continue to pay regular quarterly cash dividends, including at the increased rate, and the amounts and timing of any future dividends; information systems failures and cyberattacks; our ability to consummate and successfully integrate acquisitions; and amounts for cash and non-cash charges related to restructuring plans that may differ from original estimates, including because of timing changes associated with the underlying actions.

A comprehensive land-grant institution that enhances the quality of life in Virginia and throughout the world, Virginia Tech is an inclusive community dedicated to knowledge, discovery, and creativity.

Factors that could cause actual results to differ materially from those implied by these forward-looking statements include, but are not limited to: the final amount of charges resulting from the planned North American asset realignment and the Company’s ability to realize anticipated savings and operational benefits from the asset realignment; our ability to achieve the strategic and other objectives relating to the acquisition of Spartech Corporation, including any expected synergies; our ability to successfully integrate Spartech and achieve the expected results of the acquisition, including, without limitation, the acquisition being accretive; disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future; the financial condition of our customers, including the ability of customers (especially those that may be highly leveraged and those with inadequate liquidity) to maintain their credit availability; the speed and extent of an economic recovery, including the recovery of the housing market; our ability to achieve new business gains; the effect on foreign operations of currency fluctuations, tariffs and other political, economic and regulatory risks; changes in polymer consumption growth rates where we conduct business; changes in global industry capacity or in the rate at which anticipated changes in industry capacity come online; fluctuations in raw material prices, quality and supply and in energy prices and supply; production outages or material costs associated with scheduled or unscheduled maintenance programs; unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters; an inability to achieve or delays in achieving or achievement of less than the anticipated financial benefit from initiatives related to working capital reductions, cost reductions and employee productivity goals; an inability to raise or sustain prices for products or services; an inability to maintain appropriate relations with unions and employees; the inability to achieve expected results from our acquisition activities; our ability to continue to pay cash dividends; the amount and timing of repurchases of our common shares, if any; and other factors affecting our business beyond our control, including, without limitation, changes in the general economy, changes in interest rates and changes in the rate of inflation.

These accreditations help identify Avient as a leader in India's growing food packaging and healthcare markets by demonstrating that its materials and technologies meet distinctive quality standards in this region.

Recently Launched Colorant Chromatics™ Evoluscend™ Non-PFAS High-Temperature Mold Release Additive: a high-temperature polymer mold release additive made without intentionally added PFAS and developed to boost production efficiency and product quality for manufacturers.

This vertical integration means quality and performance can be guaranteed at every stage, allowing glove manufacturers to consistently deliver a fiber with superior performance, comfort, and durability. 

Copolyester, Polyester & PC/Polyester Blends Copolyester Eastman Tritan™ (Copolyester) High chemical resistance to a wide variety of hospital disinfectants; excellent toughness and impact resistance after disinfection; retains color and gloss after sterilization and disinfection; does not contain BPA, BPS or halogens Polybutylene Terephthalate (PBT) DuPont™ Crastin® & Rynite® (FR-PBT) 30% glass reinforced; flame retardant; good mold flow and electrical properties; high strength, stiffness, dimensional stability and heat resistance Polycarbonate/ Polyester (PC/PET) & Polycarbonate/ Polybutylene Terephthalate (PC/PBT) Covestro Makroblend® (FR-PC/PET) & (FR-PC/PBT) Strength; toughness; chemical resistance; flame retardant Covestro Makroblend® (Non-FR PC/PBT) Strength; toughness; chemical resistance; limited biocompatibility Trinseo EMERGE™ (FR-PC/PET) Chemical resistance; ignition resistance; limited biocompatibility PA, PVC, PC & PMMA Polyamide (Nylon, PA) Avient Trilliant™ XR Radiation Shielding (PA) Radiation shielding; green alternative for lead replacement; enhanced design freedom vs. lead; available in hard and soft durometers Arkema Rilsan® MED (PA11) & Rilsamid® MED (PA12) Chemical resistance; transparent and opaque; easy processing; creep resistance; temperature resistance; BPA-free; sterilizable by gamma, EtO and steam Polyvinyl Chloride (PVC) GEON Performance Solutions Resilience™ HC (PVC) Excellent chemical resistance; good strength and stiffness; very good surface quality; inherently flame resistant; available in all medical colors; excellent solvent bonding to PVC Polycarbonate (PC) Trinseo EMERGE™ (PC) Ignition resistant; transparent and opaque; glass-filled also available PolyMethyl Methacrylate (PMMA) Trinseo Plexiglas® Acrylics (PMMA) Clarity; easy processing; chemical resistance; BPA free; ideal for light piping and lenses Styrenics & FR-PC/ABS Blends Styrenics Trinseo MAGNUM™ (ABS) Opaque; custom colors; excellent impact and flow; low residuals; full biocompatibility INEOS Styrolution Terlux® HD (MABS) Good clarity; good heat and overall chemical resistance; good impact strength; good solvent bonding to PVC; outstanding surface quality INEOS Styrolution Lustran® & Novodur® HD (ABS) Opaque appearance; outstanding chemical resistance; high impact strength; excellent balance of properties; ease of processability; bondable FR- Polycarbonate/ ABS (FR-PC/ABS) Covestro Bayblend® (FR-PC/ABS) Flame retardant; good impact resistance; dimensional stability; toughness Trinseo EMERGE™ (FR-PC/ABS) Ignition resistant; limited biocompatibility; high flow; easy processing; glass-filled also available RIGID COMPONENTS: DIAGNOSTIC, IMAGING, LIFE SUPPORT, LABORATORY, & MONITORING EQUIPMENT Applications include: • Housings • Covers • Monitor bezels • Body panels • Handles • Access panels • Battery enclosures • Wands • Coils Rigid Component Solution Needs: • Materials compliant with ISO 10993 & USP Class VI, if required • UL approved resins to meet flammability requirements • Housings with toughness & good impact resistance • Enclosures & components that withstand repeated cleanings • High-flow materials for components with complex designs FLEXIBLE COMPONENTS: DIAGNOSTIC, IMAGING, LIFE SUPPORT, LABORATORY, & MONITORING EQUIPMENT Applications include: • O-rings • Gaskets • Wheels • Soft touch grips/handles • Keypads/displays • Diaphragms • Seals Flexible Component Solution Needs: • Comfortable handles & grips • Water-tight seals • Durable feet or casters • Durable keypads • Flow control TPE, TPC-ET, TPU, TPV & Flexible PVC Thermoplastic Elastomers (TPE) Avient Versaflex™ HC Overmolding Series (TPE) Proven healthcare solutions with hardness ranges 42–65 Shore A; autoclave, radiation and EtO sterilizable; bondable to many substrates; customizable haptics Arkema Pebax® MED (TPE) Sterilizable by gamma and EtO; low energy return; soft touch; chemical resistance; overmolding material Thermoplastic Polyester Elastomers (TPC-ET) DuPont™ Hytrel® (TPC-ET) Wide range of flexibility, stiffness, and processing options; Shore D between 30-82; BPA-free; excellent flex fatigue and toughness; low temperature flexibility; good chemical resistance Thermoplastic Polyurethane (TPU) Covestro Texin® (TPU) Biocompatible; soft touch; sterilizable; good chemical resistance; overmold for grips and handles; excellent bonding to polar substrates like PC; 70A to 95A Thermoplastic Vulcanizate (TPV) Avient Versalloy™ (TPV) Proven healthcare solutions with hardness ranges 45–90 Shore A; autoclave, radiation and EtO sterilizable; natural and colorable; smooth texture; bonds to PP Exxon Mobil Santoprene™ (TPV) Durable sealing performance; elastic recovery; excellent chemical resistance; compliance with medical standards Flexible Polyvinyl Chloride (PVC) GEON Performance Solutions Geon™ Flexible PVC Engineered exclusively for the healthcare market; transparent and opaque colors; radiopaque grades available; durometer ranges from 55A to 40D; gamma and EtO sterilizable Thermoset Silicone Elastomers Thermoset Silicone Elastomers/ Liquid Silicone Rubber (LSR) DuPont™ Liveo™ Silicone Elastomers (LSR) Biocompatible; non-irritating and non-sensitization; sterilizable; made without plasticizers, phthalates or latex PVC Polyvinyl Chloride (PVC) GEON Performance Solutions Geon™ Flexible PVC Inherent flame resistance; halogen-free; excellent chemical resistance; non-yellowing; proven safety record in wire and cable applications; high temperature grades available TPE, TPC-ET, TPU & POE Thermoplastic Polyester (TPE) Arkema Pebax® (TPE) Flexibility; chemical resistance; easy processing; abrasion resistance; low coefficient of friction Thermoplastic Polyester Elastomers (TPC-ET) DuPont™ Hytrel® (TPC-ET) REACH, RoHS and WEEE compliant; wide range of flexibility, stiffness, and processing options; 30D-82D; BPA-free; excellent flex fatigue and toughness; low temperature flexibility; good chemical resistance Thermoplastic Polyurethane (TPU) Covestro Texin® (TPU) RoHs, WEEE, and REACH compliant; excellent memory and recoil; abrasion resistance; Texin® Rx Series - medical grade Polyether TPU – 70A to 80D Polyolefin Elastomer (POE) Avient ECCOH™ Non-halogenated flame retardant; high flexibility; environmental stress cracking resistance (ESCR); good electrical properties PA Polyamide (Nylon, PA) Arkema Rilsan® (PA) Chemical resistance; easy processing; abrasion resistance; low coefficient of friction; dimensional stability WIRE & CABLE: DIAGNOSTIC, IMAGING, LIFE SUPPORT, LABORATORY, & MONITORING EQUIPMENT Applications include: • Plug molding • Flexible jacket • Heater cable insulation • Flexible cords • Coil cords & cable Wire & Cable Component Solution Needs: • Materials compliant with UL, RoHS, REACH & WEEE, if needed • Materials with good chemical, moisture & abrasion resistance • Low smoke & non-halogen materials CUSTOM AVIENT SOLUTIONS FOR MEDICAL EQUIPMENT Custom Solution Needs Avient™ Custom Solutions Specialized materials to meet unique application requirements Avient Trilliant™ Healthcare products are a line of customized solutions specific for regulated medical devices; color branding expertise FDA-registered pre-colored resins and masterbatch options; color coding for safety and brand recognition Avient collaborates with key material suppliers to provide FDA-approved pre-colored resins Avient OnColor™ HC Plus offers customizable color masterbatch solutions pre-certified for biocompatibility using ISO 10993 and USP Class VI test protocol Reduced growth of microbes Avient WithStand™ additive technologies inhibit growth of microbes that often cause odor, staining and loss of mechanical properties AVIENT DISTRIBUTION Healthcare Supplier Line Card You face a unique set of challenges when designing parts for the healthcare industry. In addition to maintaining an effective manufacturing and supply chain operation, you’re challenged with designing products that must meet strict regulatory and quality assurance standards.